Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> Infection

Schistosomiasis caused by <i>Schistosoma japonicum</i> is a major parasitic disease in the People&#8217;s Republic of China. Liver fibrosis is the main pathological mechanism of schistosomiasis, and it is also the major lesion. The common drug used for its treatment, praziquantel (PZ...

Full description

Bibliographic Details
Main Authors: Tina Tuwen Chen, Shihyi Peng, Yanjuan Wang, Yuan Hu, Yujuan Shen, Yuxin Xu, Jianhai Yin, Congshan Liu, Jianping Cao
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/9/11/658
id doaj-756f73816ec4407f9d449704541f4046
record_format Article
spelling doaj-756f73816ec4407f9d449704541f40462020-11-25T00:10:07ZengMDPI AGBiomolecules2218-273X2019-10-0191165810.3390/biom9110658biom9110658Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> InfectionTina Tuwen Chen0Shihyi Peng1Yanjuan Wang2Yuan Hu3Yujuan Shen4Yuxin Xu5Jianhai Yin6Congshan Liu7Jianping Cao8National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaDepartment of Biochemistry, School of Medicine, Tzu Chi University, Hualien 97004, TaiwanNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, MOH, Shanghai 200025, ChinaSchistosomiasis caused by <i>Schistosoma japonicum</i> is a major parasitic disease in the People&#8217;s Republic of China. Liver fibrosis is the main pathological mechanism of schistosomiasis, and it is also the major lesion. The common drug used for its treatment, praziquantel (PZQ), does not have a marked effect on liver fibrosis. Resveratrol (RSV), which is an antioxidant, improves mitochondrial function and also attenuates liver fibrosis. The combination of PZQ and RSV has been found to have a synergistic antischistosomal effect on <i>Schistosoma mansoni</i>; additionally, the activity of PZQ is enhanced in the presence of RSV. Here, we examine the therapeutic effects of RSV on the <i>S. japonicum</i> infection in a mouse model, and we investigate RSV as a novel therapeutic agent for mitochondrial function and schistosomiasis-associated liver fibrosis (SSLF). Mitochondrial membrane potential was examined using flow cytometry analysis. The expression of the mitochondrial biogenesis genes PGC-&#945; and fibrosis-associated genes collagen I, collagen III and &#945;-SMA were examined using western blot analysis. Fibrosis-associated histological changes were examined using Masson trichrome staining. Additionally, the effects of RSV on <i>S. japonicum</i> adult worms were examined using scanning electron microscopy and transmission electron microscopy. RSV treatment improved mitochondrial function by increasing membrane potential and increasing PGC-&#945; expression (mitochondrial biogenesis). Further, RSV attenuated liver injury, including liver scarring, by decreasing collagen deposition and the extent of fibrosis, based on the decrease in expression of the fibrosis-related genes. RSV also decreased the adult worm count and caused considerable physical damage to the worm. These results indicate that RSV upregulates mitochondrial biogenesis and inhibits fibrosis. RSV may have potential as a therapeutic target for the treatment of fibrosis in schistosomiasis.https://www.mdpi.com/2218-273X/9/11/658schistosomiasis<i>schistosoma japonicum</i> (<i>s. japonicum</i>)resveratrol (rsv)schistosomiasis-associated liver fibrosis (sslf)mitochondrial function<i>s. japonicum</i> adult worm
collection DOAJ
language English
format Article
sources DOAJ
author Tina Tuwen Chen
Shihyi Peng
Yanjuan Wang
Yuan Hu
Yujuan Shen
Yuxin Xu
Jianhai Yin
Congshan Liu
Jianping Cao
spellingShingle Tina Tuwen Chen
Shihyi Peng
Yanjuan Wang
Yuan Hu
Yujuan Shen
Yuxin Xu
Jianhai Yin
Congshan Liu
Jianping Cao
Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> Infection
Biomolecules
schistosomiasis
<i>schistosoma japonicum</i> (<i>s. japonicum</i>)
resveratrol (rsv)
schistosomiasis-associated liver fibrosis (sslf)
mitochondrial function
<i>s. japonicum</i> adult worm
author_facet Tina Tuwen Chen
Shihyi Peng
Yanjuan Wang
Yuan Hu
Yujuan Shen
Yuxin Xu
Jianhai Yin
Congshan Liu
Jianping Cao
author_sort Tina Tuwen Chen
title Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> Infection
title_short Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> Infection
title_full Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> Infection
title_fullStr Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> Infection
title_full_unstemmed Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with <i>Schistosoma japonicum</i> Infection
title_sort improvement of mitochondrial activity and fibrosis by resveratrol treatment in mice with <i>schistosoma japonicum</i> infection
publisher MDPI AG
series Biomolecules
issn 2218-273X
publishDate 2019-10-01
description Schistosomiasis caused by <i>Schistosoma japonicum</i> is a major parasitic disease in the People&#8217;s Republic of China. Liver fibrosis is the main pathological mechanism of schistosomiasis, and it is also the major lesion. The common drug used for its treatment, praziquantel (PZQ), does not have a marked effect on liver fibrosis. Resveratrol (RSV), which is an antioxidant, improves mitochondrial function and also attenuates liver fibrosis. The combination of PZQ and RSV has been found to have a synergistic antischistosomal effect on <i>Schistosoma mansoni</i>; additionally, the activity of PZQ is enhanced in the presence of RSV. Here, we examine the therapeutic effects of RSV on the <i>S. japonicum</i> infection in a mouse model, and we investigate RSV as a novel therapeutic agent for mitochondrial function and schistosomiasis-associated liver fibrosis (SSLF). Mitochondrial membrane potential was examined using flow cytometry analysis. The expression of the mitochondrial biogenesis genes PGC-&#945; and fibrosis-associated genes collagen I, collagen III and &#945;-SMA were examined using western blot analysis. Fibrosis-associated histological changes were examined using Masson trichrome staining. Additionally, the effects of RSV on <i>S. japonicum</i> adult worms were examined using scanning electron microscopy and transmission electron microscopy. RSV treatment improved mitochondrial function by increasing membrane potential and increasing PGC-&#945; expression (mitochondrial biogenesis). Further, RSV attenuated liver injury, including liver scarring, by decreasing collagen deposition and the extent of fibrosis, based on the decrease in expression of the fibrosis-related genes. RSV also decreased the adult worm count and caused considerable physical damage to the worm. These results indicate that RSV upregulates mitochondrial biogenesis and inhibits fibrosis. RSV may have potential as a therapeutic target for the treatment of fibrosis in schistosomiasis.
topic schistosomiasis
<i>schistosoma japonicum</i> (<i>s. japonicum</i>)
resveratrol (rsv)
schistosomiasis-associated liver fibrosis (sslf)
mitochondrial function
<i>s. japonicum</i> adult worm
url https://www.mdpi.com/2218-273X/9/11/658
work_keys_str_mv AT tinatuwenchen improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT shihyipeng improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT yanjuanwang improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT yuanhu improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT yujuanshen improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT yuxinxu improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT jianhaiyin improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT congshanliu improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
AT jianpingcao improvementofmitochondrialactivityandfibrosisbyresveratroltreatmentinmicewithischistosomajaponicumiinfection
_version_ 1725409310153900032